PT851876E - Peptido factor anti-secretorio regulador das alteracoes patologicas da permeabilidade - Google Patents

Peptido factor anti-secretorio regulador das alteracoes patologicas da permeabilidade

Info

Publication number: PT851876E
Authority: PT; Portugal
Prior art keywords: homologues; fragments; permeability; protein; raf
Prior art date: 1995-08-24

Application number

PT96929619T

Other languages

English (en)

Inventor

Stefan Lange

Ivar Lonnroth

Eva Johansson

Eva Jennische

Christina Lonnroth

Original Assignee

Rural Patent Svenska Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-24

Filing date

1996-08-23

Publication date

2004-10-29

1996-08-23 Application filed by Rural Patent Svenska Ab filed Critical Rural Patent Svenska Ab

2004-10-29 Publication of PT851876E publication Critical patent/PT851876E/pt

Links

108010038288 antisecretory factor Proteins 0.000 title abstract 2
230000001575 pathological effect Effects 0.000 title abstract 2
230000004075 alteration Effects 0.000 title 1
230000035699 permeability Effects 0.000 title 1
230000001105 regulatory effect Effects 0.000 title 1
239000012634 fragment Substances 0.000 abstract 4
206010061218 Inflammation Diseases 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 2
230000004054 inflammatory process Effects 0.000 abstract 2
108020004707 nucleic acids Proteins 0.000 abstract 2
102000039446 nucleic acids Human genes 0.000 abstract 2
150000007523 nucleic acids Chemical class 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
206010030113 Oedema Diseases 0.000 abstract 1
108010033276 Peptide Fragments Proteins 0.000 abstract 1
102000007079 Peptide Fragments Human genes 0.000 abstract 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
239000003674 animal food additive Substances 0.000 abstract 1
230000001142 anti-diarrhea Effects 0.000 abstract 1
230000018044 dehydration Effects 0.000 abstract 1
238000006297 dehydration reaction Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Zoology (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Polymers & Plastics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Food Science & Technology (AREA)
Animal Husbandry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Immunology (AREA)
Pulmonology (AREA)

PT96929619T 1995-08-24 1996-08-23 Peptido factor anti-secretorio regulador das alteracoes patologicas da permeabilidade PT851876E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9502936A SE508609C2 (sv)	1995-08-24	1995-08-24	Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning

Publications (1)

Publication Number	Publication Date
PT851876E true PT851876E (pt)	2004-10-29

Family

ID=20399269

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96929619T PT851876E (pt)	1995-08-24	1996-08-23	Peptido factor anti-secretorio regulador das alteracoes patologicas da permeabilidade

Country Status (28)

Country	Link
US (2)	US6344440B1 (pt)
EP (1)	EP0851876B1 (pt)
JP (2)	JP4040679B2 (pt)
KR (1)	KR100552947B1 (pt)
CN (1)	CN1171902C (pt)
AT (1)	ATE270305T1 (pt)
AU (1)	AU702589B2 (pt)
BG (1)	BG63209B1 (pt)
BR (1)	BR9610308A (pt)
CA (1)	CA2230111C (pt)
CZ (1)	CZ295444B6 (pt)
DE (2)	DE851876T1 (pt)
DK (1)	DK0851876T3 (pt)
EA (1)	EA001201B1 (pt)
EE (1)	EE04501B1 (pt)
ES (1)	ES2118683T3 (pt)
HU (1)	HU224971B1 (pt)
IL (1)	IL123404A (pt)
NO (1)	NO320560B1 (pt)
NZ (2)	NZ316647A (pt)
PL (1)	PL188530B1 (pt)
PT (1)	PT851876E (pt)
RO (1)	RO120197B1 (pt)
SE (1)	SE508609C2 (pt)
SI (1)	SI0851876T1 (pt)
SK (1)	SK23698A3 (pt)
TR (1)	TR199800304T1 (pt)
WO (1)	WO1997008202A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE508609C2 (sv) *	1995-08-24	1998-10-19	Rural Patent Svenska Ab	Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
SE9604251L (sv) *	1996-11-20	1997-12-22	Svenska Lantmaennen Riksfoerbu	Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) *	1998-12-17	2000-09-18	Rural Patent Svenska Ab	NASP-berikad äggula samt dess användning
CN1335887A (zh) *	1999-06-21	2002-02-13	印坎药物股份有限公司	血管抑制素∶一种Cys－Ser－Val－Thr－Cys－Gly特异性肿瘤细胞粘附受体
GB0322645D0 (en) *	2003-09-26	2003-10-29	Melacure Therapeutics Ab	Use of antisecretory factor peptides
MX2008013777A (es)	2006-04-27	2009-02-03	Lantmaennen As Faktor Ab	Usos medicos adicionales de la proteina antisecretora.
BRPI0710858A2 (pt)	2006-04-27	2011-05-17	Lantmonnen As Faktor Ab	uso de uma proteìna anti-secretora, um derivado, homólogo e/ou fragmento da mesma, tendo atividade anti-secretora, e/ou um sal farmaceuticamente ativo da mesma
PL2015767T3 (pl) *	2006-04-27	2016-05-31	Lantmaennen As Faktor Ab	Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
RU2341981C2 (ru) *	2006-07-03	2008-12-27	Государственное учреждение Всероссийский научно-исследовательский институт пищевых ароматизаторов, кислот и красителей Российской академии сельскохозяйственных наук (ГУ ВНИИПАКК)	Комплексная пищевая добавка
WO2010065342A1 (en)	2008-11-25	2010-06-10	Temple University	Angiocidin inhibition of tumor cell growth
EP2396024A4 (en)	2009-02-11	2013-02-27	Lantmaennen As Faktor Ab	USE OF ANTISECRREATORY FACTORS (AF) FOR OPTIMIZATION OF CELLULAR ABSORPTION
CN107949392B (zh) *	2015-07-10	2022-10-11	兰特门内阿斯-法克托尔公司	用于生产含高含量af-16的蛋黄的方法
JP6999638B2 (ja) *	2016-07-18	2022-01-18	ラントメネン・メディカル・アーベー	抗分泌性因子１７
CA3103164A1 (en)	2018-06-28	2020-01-02	Lantmannen Medical Ab	Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
WO2020065089A2 (en)	2018-09-28	2020-04-02	Lantmännen Functional Foods Ab	A consumable product comprising malted dehulled oat
WO2020065091A1 (en)	2018-09-28	2020-04-02	Lantmännen Functional Foods Ab	A consumable product comprising malted wheat
CN115605214A (zh)	2020-03-26	2023-01-13	兰特门内保健食品公司（Se）	用于促进身体活动恢复的包含麦芽化谷物的可消耗产品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE508609C2 (sv) *	1995-08-24	1998-10-19	Rural Patent Svenska Ab	Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning

1995
- 1995-08-24 SE SE9502936A patent/SE508609C2/sv not_active IP Right Cessation
1996
- 1996-08-23 US US09/029,333 patent/US6344440B1/en not_active Expired - Lifetime
- 1996-08-23 PL PL96325114A patent/PL188530B1/pl unknown
- 1996-08-23 AT AT96929619T patent/ATE270305T1/de active
- 1996-08-23 EE EE9800055A patent/EE04501B1/xx not_active IP Right Cessation
- 1996-08-23 EA EA199800221A patent/EA001201B1/ru not_active IP Right Cessation
- 1996-08-23 BR BR9610308-6A patent/BR9610308A/pt not_active IP Right Cessation
- 1996-08-23 AU AU68932/96A patent/AU702589B2/en not_active Expired
- 1996-08-23 CN CNB961973005A patent/CN1171902C/zh not_active Expired - Lifetime
- 1996-08-23 IL IL12340496A patent/IL123404A/xx not_active IP Right Cessation
- 1996-08-23 RO RO98-00364A patent/RO120197B1/ro unknown
- 1996-08-23 ES ES96929619T patent/ES2118683T3/es not_active Expired - Lifetime
- 1996-08-23 KR KR1019980701343A patent/KR100552947B1/ko not_active Expired - Lifetime
- 1996-08-23 SI SI9630013T patent/SI0851876T1/xx unknown
- 1996-08-23 EP EP96929619A patent/EP0851876B1/en not_active Expired - Lifetime
- 1996-08-23 DK DK96929619T patent/DK0851876T3/da active
- 1996-08-23 WO PCT/SE1996/001049 patent/WO1997008202A1/en not_active Ceased
- 1996-08-23 SK SK236-98A patent/SK23698A3/sk unknown
- 1996-08-23 CZ CZ1998520A patent/CZ295444B6/cs not_active IP Right Cessation
- 1996-08-23 PT PT96929619T patent/PT851876E/pt unknown
- 1996-08-23 NZ NZ316647A patent/NZ316647A/en not_active IP Right Cessation
- 1996-08-23 CA CA2230111A patent/CA2230111C/en not_active Expired - Lifetime
- 1996-08-23 JP JP51018597A patent/JP4040679B2/ja not_active Expired - Lifetime
- 1996-08-23 HU HU9900137A patent/HU224971B1/hu unknown
- 1996-08-23 DE DE0851876T patent/DE851876T1/de active Pending
- 1996-08-23 DE DE69632828T patent/DE69632828T2/de not_active Expired - Lifetime
- 1996-08-23 TR TR1998/00304T patent/TR199800304T1/xx unknown
1998
- 1998-02-23 NO NO19980743A patent/NO320560B1/no not_active IP Right Cessation
- 1998-02-24 BG BG102280A patent/BG63209B1/bg unknown
1999
- 1999-08-20 NZ NZ337380A patent/NZ337380A/en not_active IP Right Cessation
2001
- 2001-11-26 US US09/991,792 patent/US20020099016A1/en not_active Abandoned
2007
- 2007-07-25 JP JP2007193054A patent/JP2008043331A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
ES2118683T3 (es)	2004-12-01
EA199800221A1 (ru)	1998-10-29
BG63209B1 (bg)	2001-06-29
IL123404A0 (en)	1998-09-24
ATE270305T1 (de)	2004-07-15
EP0851876B1 (en)	2004-06-30
SE508609C2 (sv)	1998-10-19
BG102280A (en)	1999-04-30
HUP9900137A2 (hu)	1999-04-28
SE9502936D0 (sv)	1995-08-24
CZ295444B6 (cs)	2005-08-17
NO980743L (no)	1998-04-16
CZ52098A3 (cs)	1998-09-16
DE69632828D1 (de)	2004-08-05
SI0851876T1 (en)	2004-10-31
HK1018468A1 (en)	1999-12-24
EA001201B1 (ru)	2000-12-25
CA2230111C (en)	2012-10-30
NO320560B1 (no)	2005-12-19
CN1208420A (zh)	1999-02-17
IL123404A (en)	2005-07-25
WO1997008202A1 (en)	1997-03-06
JP2008043331A (ja)	2008-02-28
KR19990044110A (ko)	1999-06-25
DE69632828T2 (de)	2005-07-14
NZ337380A (en)	2001-02-23
AU702589B2 (en)	1999-02-25
SE9502936L (sv)	1997-02-25
DE851876T1 (de)	1998-11-12
NZ316647A (en)	1999-10-28
PL188530B1 (pl)	2005-02-28
SK23698A3 (en)	1998-12-02
JPH11511972A (ja)	1999-10-19
EP0851876A1 (en)	1998-07-08
US6344440B1 (en)	2002-02-05
CN1171902C (zh)	2004-10-20
KR100552947B1 (ko)	2006-04-21
AU6893296A (en)	1997-03-19
PL325114A1 (en)	1998-07-06
JP4040679B2 (ja)	2008-01-30
US20020099016A1 (en)	2002-07-25
CA2230111A1 (en)	1997-03-06
ES2118683T1 (es)	1998-10-01
NO980743D0 (no)	1998-02-23
HU224971B1 (en)	2006-04-28
DK0851876T3 (da)	2004-10-25
HUP9900137A3 (en)	1999-11-29
EE04501B1 (et)	2005-06-15
TR199800304T1 (xx)	1998-05-21
RO120197B1 (ro)	2005-10-28
EE9800055A (et)	1998-08-17
BR9610308A (pt)	1999-12-21

Publication	Publication Date	Title
PT851876E (pt)	2004-10-29	Peptido factor anti-secretorio regulador das alteracoes patologicas da permeabilidade
DE69534235D1 (de)	2005-06-30	Cytokin lerk-7
NO990086L (no)	1999-03-09	Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
HK49285A (en)	1985-07-05	Interferons and process for their preparation
ATE295414T1 (de)	2005-05-15	Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
ES8306324A1 (es)	1983-06-01	"proceso para la produccion microbiana de interferon fibroblasto humano".
DK555082A (da)	1982-12-14	B.thuringiensis krystalprotein i e.coli.
ES2137931T3 (es)	2000-01-01	Proteinas gdf-1 y uog-1.
ATE242323T1 (de)	2003-06-15	Transportprotein, das den transport von kationischen xenobiotika und/oder pharmaka bewirkt, dafür kodierende dna-sequenzen und deren verwendung
DE68925869D1 (de)	1996-04-11	Modifizierte Proteine, modifizierte Interferone alpha- und beta-phosphorylierte Proteine, DNA-Sequenzen und Analoge und deren Verwendung
ATE271603T1 (de)	2004-08-15	Identifizierungsverfahren für substanzen die an das pyk2 polypeptid binden
FI841288A7 (fi)	1984-10-01	Rekombinaatti-DNA-koodaus polypeptidin ilmaisemiseksi.
FR2533637B1 (fr)	1986-02-28	Pompe cryogenique
IT8219190A0 (it)	1982-01-19	Tecnica elettroforetica migliorata per separare sieroproteine e gel elettroforetico migliorato per tale impiego.
FI852761L (fi)	1986-01-13	Direkt fingeravlaesning.
DK400786A (da)	1987-03-18	Udtrykkelsesvektorer til anvendelse i e. coli
FI943218A7 (fi)	1994-07-05	Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja k äytöt
EP0676413A3 (en)	1996-04-03	Interferon alpha / beta binding protein, its production and application.
DK551786A (da)	1987-09-08	Rekombinant-dna-sekvens, der koder for aminosyresekvenser i et toksin, expressionssystem omfattende samme og vaertsceller transformeret hermed
ATE118819T1 (de)	1995-03-15	Dna moleküle, welche plazentales rinder-lactogen- peptid und das pre-peptid kodieren und genetisch transformierte zellen, die diese moleküle enthalten.
ATE236979T1 (de)	2003-04-15	Leishmania hauptprotein, dafür kodierende nukleinsaüre und verwendungen davon
Zamorska et al.	1977	Rat interferons. Homologous and heterologus rat serum activity
IT8485664A0 (it)	1984-11-29	Procedimento per il trattamento di liquami di conceria con ricupero di torbide proteiche utilizzabili in zootecnia.
NO824348L (no)	1982-12-23	B. thuringiensis krystallprotein i e. coli.
IT8019033A0 (it)	1980-01-04	Metodo per il trattamento disuperfici siero-essudanti dell'epidermide, ferite, piaghe esimili, e mezzi per la sua attuazione.